aTyr Pharma, Inc. (ATYR)
NASDAQ·Healthcare·Biotechnology
$0.79
+0.22%
Mkt Cap $77.55M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$5.13
Range $1.00 – $17.00
Implied Upside
+547.2%
Consensus $5.13 vs current $0.79
NASDAQ·Healthcare·Biotechnology
$0.79
+0.22%
Mkt Cap $77.55M
No recent rating data.
Price Target (4 analysts)
$5.13
Range $1.00 – $17.00
+547.2%
Consensus $5.13 vs current $0.79